A multicolor immunochromatographic assay kit and its detection method based on glucose oxidase-driven aggregation-induced luminescent nanomotors.
By using a glucose oxidase-driven aggregation-induced light-emitting nanomotor, the problem of low probe migration efficiency and insufficient multi-target detection capability in traditional immunochromatographic assays is solved, enabling rapid detection with high sensitivity and multicolor immunochromatographic test strips, suitable for various detection scenarios.
Patent Information
- Application Number
- CN202611318592.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-28
- Publication Date
- 2026-11-10
AI Technical Summary
Traditional immunochromatographic test strips suffer from problems such as low probe migration efficiency, insufficient immunobinding kinetics, limited detection sensitivity, and insufficient multi-target detection capability. Furthermore, existing nanomotor detection methods are dependent on external equipment, have high preparation costs, are complex to operate, or lack compatibility with paper-based chromatography systems.
An aggregation-induced emission nanomotor driven by glucose oxidase is employed, using PS-AIE-SiO2@GOx nanocomposite material as an immunoprobe. AIE fluorescent molecules form a stable confined structure inside the polymer microspheres, which, combined with the glucose oxidase catalytic reaction, generates a self-driving force to achieve active movement, thereby enhancing the contact probability and binding efficiency between the probe and the target antigen. Multi-target detection is achieved through multi-color fluorescence signal output.
It improves the stability and sensitivity of detection, simplifies the detection process, is suitable for multi-target detection, is suitable for integration with paper-based analytical detection platforms, and is applicable to fields such as clinical diagnosis, food safety, and pathogen detection.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention relates to the field of immunoassay technology, specifically to a multicolor immunochromatographic assay kit and its detection method based on glucose oxidase-driven aggregation-induced luminescence nanomotors. Background Technology
[0002] Immunochromatographic test strips are widely used in clinical diagnostics, food safety, environmental monitoring, and pathogen detection due to their advantages such as simple operation, rapid detection, low cost, and suitability for on-site testing. Traditional immunochromatographic test strips often use colloidal gold, colored latex microspheres, or ordinary fluorescent microspheres as signal markers. However, colloidal gold has limited signal intensity, making it difficult to meet the high-sensitivity detection requirements of low-abundance targets. While ordinary fluorescent probes can improve detection sensitivity, traditional fluorescent dyes are prone to aggregation-induced quenching under high loading or aggregation conditions, leading to reduced fluorescence signal and decreased stability. Furthermore, most existing immunochromatographic test strips have a single signal channel, making it difficult to achieve multi-target, multi-color differentiation detection.
[0003] The migration efficiency and immunobinding efficiency of labeled probes directly affect detection sensitivity during immunochromatographic assays. Nanomotors can generate active motion under the influence of chemical reactions, light, magnetic fields, or other external stimuli, thereby increasing the probability of collision and binding between probes and targets. While existing light-driven or noble metal-catalyzed nanomotors can be used to enhance detection signals, they typically suffer from problems such as dependence on external equipment, high preparation costs, complex operation, or insufficient compatibility with paper-based chromatography systems.
[0004] Existing chemiluminescence immunoassay methods typically require the addition of chemiluminescent substrates, catalytic reagents, or auxiliary reaction systems. The detection process relies on complex signal activation steps, making it difficult to achieve simple, rapid, and on-site detection. Furthermore, the integration of chemiluminescence immunoassay detection systems with traditional immunochromatographic test strips still faces certain limitations. Summary of the Invention
[0005] To overcome the shortcomings of the existing technology, the present invention aims to provide a multicolor immunochromatographic assay kit and its detection method based on glucose oxidase-driven aggregation-induced emission nanomotors. This multicolor immunochromatographic assay kit solves the problems of low probe migration efficiency, insufficient immune binding kinetics, limited detection sensitivity, and insufficient multi-target detection capability in traditional immunochromatographic assays.
[0006] To achieve the above objectives, the technical solution adopted by the present invention is as follows: A multicolor immunochromatographic assay kit based on a glucose oxidase-driven aggregation-induced emission nanomotor includes a multicolor immunochromatographic test strip and individually packaged immunoprobe reagents. The multicolor immunochromatographic test strip includes a base plate and a sample pad, filter paper, nitrocellulose membrane, and absorbent paper sequentially overlapped and adhered to the base plate. The immunoprobe reagent is PBSG@mAb buffer. The PBSG@mAb buffer is prepared from a PS-AIE-SiO2@GOx nanocomposite material and an antibody to be labeled. The PS-AIE-SiO2@GOx nanocomposite material consists of asymmetric snowman-shaped nanoparticles, one end of which is an aggregation-induced emission polystyrene nanosphere PS-AIE, and the other end is a hemispherical SiO2 nanoparticle modified with glucose oxidase GOx.
[0007] Furthermore, the aggregation-induced emission polystyrene nanospheres PS-AIE are prepared by encapsulating AIE fluorescent molecules in polystyrene nanospheres PS, and the diameter of the aggregation-induced emission polystyrene nanospheres PS-AIE is 150 nm to 250 nm.
[0008] Furthermore, the AIE fluorescent molecule is selected from one of the following: green AIE fluorescent molecule BTPEBT, red AIE fluorescent molecule DPNA-BT, and blue AIE fluorescent molecule TPE.
[0009] Furthermore, the glucose oxidase GOx is modified on the surface of hemispherical SiO2 nanoparticles by any one of the following methods: physical adsorption, covalent coupling, silanization modification, amination modification, carboxylation modification, glutaraldehyde crosslinking, or EDC / NHS coupling.
[0010] Furthermore, the PBSG@mAb buffer is prepared by mixing 1~20mg of PS-AIE-SiO2@GOx nanocomposite material with 5 μg of antibody to be labeled, incubating for 30~150 min, adding blocking agent, continuing incubation at room temperature for 20~120 min, centrifuging to collect the precipitate, and reconstituted.
[0011] Furthermore, the antibody to be labeled is selected from one of monoclonal antibodies, polyclonal antibodies, nanobodies, and phage expression antibodies.
[0012] Furthermore, the preparation method of the PS-AIE-SiO2@GOx nanocomposite material is as follows: 1) Preparation of aggregation-induced emission polystyrene nanospheres PS-AIE; 3.0 mL of 6 mM potassium persulfate and 3.0 mL of 1 mM sodium dodecyl sulfate were added to 5.6 mL of ultrapure water and sonicated to obtain a first dispersion. 15 mg of AIE fluorescent molecules were added to 1 mL of styrene monomer and sonicated to obtain a second dispersion. All of the first dispersion was added dropwise to all of the second dispersion, and after sonication, polymerization was carried out under an inert gas atmosphere at 60–80 °C and 100–600 rpm for 10–30 h to obtain a first mixed reaction solution. The first mixed reaction solution was centrifuged, washed, and dried sequentially to obtain PS-AIE aggregation-induced emission polystyrene nanospheres (PS-AIE). 2) Preparation of PS-AIE-SiO2 asymmetric nanoparticles; 1 g of the aggregation-induced emission polystyrene nanospheres PS-AIE prepared in step 1) was dispersed in 20 mL of ultrapure water. 8.0 μL of ammonia solution with a mass fraction of 28% was added. The mixture was stirred at room temperature and then heated to 70-75 °C with further stirring to obtain an alkaline dispersion containing PS-AIE nanospheres. 20.0 mg of potassium persulfate was dissolved in 12 mL of ultrapure water. 0.02 g of sodium dodecyl sulfate and 1.0 g of 3-methacryloyloxypropyltrimethoxysilane were added sequentially. After ultrasonic treatment, a silicon-containing emulsion was obtained. Under stirring conditions of 70-75 °C and 300-500 rpm, the entire silicon-containing emulsion was added dropwise to the entire alkaline dispersion containing PS-AIE nanospheres within 20 min. The polymerization reaction was carried out at 70-75 °C for 10-14 h to obtain a second mixed reaction solution. The second mixed reaction solution was centrifuged, and the precipitate was collected. After washing, the precipitate was dispersed in ethanol to obtain PS-AIE-SiO2 asymmetric nanoparticles. 3) Preparation of PS-AIE-SiO2@GOx nanocomposite materials; 10 mg of the PS-AIE-SiO2 asymmetric nanoparticles prepared in step 2) were dispersed in 5 mL of ethanol, and then 50 μL of 97% 3-aminopropyltriethoxysilane and 100 μL of 28% concentrated ammonia were added. The mixture was stirred and heated at 60-70 °C and 300-400 rpm for 5-8 h to obtain a third mixed reaction solution. The third mixed reaction solution was centrifuged and washed sequentially to obtain aminated PS-AIE-SiO2 nanoparticles. 5-10 mg of the aminated PS-AIE-SiO2 nanoparticles were dispersed in 5 mL of phosphate buffer, and 1 mL of 2.5% glutaraldehyde aqueous solution was added. The mixture was shaken at room temperature for 2-4 h to obtain a fourth mixed reaction solution. The fourth mixed reaction solution was centrifuged and washed sequentially to obtain activated PS-AIE-SiO2 nanoparticles. 5-10 mg of the activated PS-AIE-SiO2 nanoparticles were redispersed in 5 mL of phosphate buffer, and 1-10 mg of glutaraldehyde aqueous solution was added. mg of glucose oxidase GOx was incubated at room temperature for 4-12 h to obtain the fifth mixed reaction solution. After centrifugation of the fifth mixed reaction solution, the precipitate was collected, washed, and redissolved in PBS buffer to obtain the PS-AIE-SiO2@GOx nanocomposite material.
[0013] Furthermore, multiple detection lines and one control line are sequentially arranged on the nitrocellulose membrane along the chromatography direction; the multiple detection lines are formed by spraying capture antibodies of various different target analytes onto the surface of the nitrocellulose membrane, and the control line is formed by spraying a binding protein for recognizing PBSG@mAb onto the surface of the nitrocellulose membrane; the binding protein for recognizing PBSG@mAb is selected from one of anti-mouse antibody, anti-rabbit antibody, and streptavidin.
[0014] Furthermore, it also includes a housing for containing multicolor immunochromatographic test strips, the housing having a sample application well and an observation window; the sample application well corresponds to the position of the sample pad, and the observation window corresponds to the position of the nitrocellulose membrane.
[0015] A detection method based on a multicolor immunochromatographic assay kit for glucose oxidase-driven aggregation-induced luminescent nanomotors, wherein the multicolor immunochromatographic assay kit described above is used to detect the sample, specifically: PBSG@mAb buffer and the test sample are added to the enzyme-labeled well reactor, respectively. The mixture of PBSG@mAb buffer and the test sample is then added dropwise to the sample wells of the multicolor immunochromatographic assay kit, allowing the mixture to enter the multicolor immunochromatographic strip for immunochromatographic reaction. After 15 minutes of reaction, the signal data of the test line and control line on the multicolor immunochromatographic assay strip are read. The concentration of the test sample is calculated using the built-in standard curve to achieve quantitative detection. Qualitative judgment is achieved by observing the presence or absence of brown-red on the test line and control line through the observation window of the multicolor immunochromatographic assay kit. The sample volume of the PBSG@mAb buffer and test sample mixture is 50-150 μL / strip. The multicolor immunochromatographic assay strip needs to be irradiated with near-infrared light for 1-10 minutes during the immunochromatographic reaction.
[0016] Compared with the prior art, the beneficial effects of the present invention are as follows: 1. This invention uses aggregation-induced emission polystyrene nanospheres as a fluorescent signal carrier, which can effectively avoid the fluorescence quenching problem caused by traditional fluorescent materials under high load or aggregation state, so that the obtained immunoprobe reagent can be excited with a strong fluorescent signal on the multicolor immunochromatographic test strip, thereby effectively improving the detection stability and detection sensitivity of the multicolor immunochromatographic test strip.
[0017] 2. The immunoprobe reagent of the present invention is prepared from PS-AIE-SiO2@GOx nanocomposite material and antibody to be labeled. The PS-AIE-SiO2@GOx nanocomposite material consists of asymmetric snowman-shaped nanoparticles. One end is an aggregation-induced emission polystyrene nanosphere, which utilizes the AIE fluorescent molecule aggregation-induced emission mechanism to form a stable confined structure inside the polymer microsphere, achieving high-intensity, multi-color tunable fluorescence signal output. The other end is a hemispherical SiO2 nanoparticle modified with glucose oxidase, which utilizes glucose oxidase (GOx) to catalyze the generation of a local chemical reaction gradient of glucose, through asymmetric... The structure generates a self-driving force, enabling the immunoprobe to move actively within the detection system. This increases the contact probability and binding efficiency between the probe and the target antigen, solving the problems of traditional immunochromatographic probes, which mainly rely on capillary action for passive migration, have low mass transfer efficiency, and long immunobinding time. The asymmetric snowman-like structure facilitates directional movement, while glucose oxidase, in the presence of glucose (found in the test sample), catalyzes a reaction that generates local chemical driving force. This promotes the migration, collision, and enrichment of the immunoprobe reagent in the multicolor immunochromatographic test strip chromatographic system, thereby improving immunobinding efficiency and detection sensitivity.
[0018] 3. The aggregation-induced emission polystyrene nanospheres of the present invention are embedded with AIE fluorescent molecules of different colors. Different aggregation-induced emission polystyrene nanospheres are prepared by using AIE fluorescent molecules of different colors, thereby constructing multi-colored PBSG@mAb immunoprobes. At the same time, multiple detection lines are sequentially set on the nitrocellulose membrane along the chromatography direction. By coupling the multi-colored PBSG@mAb immunoprobes with capture antibodies of different target analytes on the multiple detection lines, the simultaneous detection of multiple target analytes can be achieved, thus improving the multi-target detection capability of the multi-color immunochromatographic test strip.
[0019] 4. This invention uses a glucose oxidase-driven method, which does not require a magnetic field or large driving equipment. The reaction conditions are mild, the system has good compatibility, and it is suitable for integration with paper-based analytical detection platforms.
[0020] 5. The multicolor immunochromatographic test strip provided by this invention can achieve qualitative or quantitative detection by reading the fluorescence color and / or fluorescence intensity at the detection line. The detection process is simple and applicable to fields such as clinical diagnosis, food safety, environmental monitoring and pathogen detection.
[0021] 6. Compared with existing ordinary fluorescent immunochromatographic test strips and traditional chemiluminescence detection methods, this invention has the advantages of not requiring a complex signal amplification system, fast detection speed, and high signal stability.
[0022] In summary, this invention employs an active migration-enhanced immunochromatographic detection technique combining multicolor AIE fluorescence encoding with a glucose-driven nanomotor. By constructing an integrated nanoprobe with active movement capability, high-brightness fluorescence output, and specific immune recognition, it solves the problems of low probe migration efficiency, insufficient immune binding kinetics, limited detection sensitivity, and insufficient multi-target detection capability in traditional immunochromatographic detection. This results in rapid, highly sensitive, and multi-channel detection, characterized by no external driving required, stable signal, high detection efficiency, and wide applicability. Attached Figure Description Figure 1 This is a TEM image of the PS-AIE aggregation-induced emission polystyrene nanospheres prepared in Example 2 of the present invention.
[0023] Figure 2 This is a TEM image of the PS-AIE-SiO2 asymmetric nanoparticles prepared in Example 2 of the present invention.
[0024] Figure 3 This is a SEM image of the PS-AIE-SiO2 asymmetric nanoparticles prepared in Example 2 of the present invention.
[0025] Figure 4 This is a SEM image of the PS-AIE-SiO2@GOx nanocomposite material prepared in Example 2 of the present invention.
[0026] Figure 5 The particle size comparison diagram shows the PS-AIE aggregation-induced emission polystyrene nanospheres, PS-AIE-SiO2 asymmetric nanoparticles, and PS-AIE-SiO2@GOx nanocomposites prepared in Example 2 of this invention.
[0027] Figure 6 The elemental distribution diagram is shown for the PS-AIE-SiO2@GOx nanocomposite material prepared in Example 2 of this invention.
[0028] Figure 7 The fluorescence emission spectrum of the unmodified green PS-AIE-SiO2 asymmetric nanoparticles prepared in Comparative Example 1 of this invention is shown.
[0029] Figure 8 This is a laser confocal image of the unmodified PS-AIE-SiO2 asymmetric nanoparticles prepared in Comparative Example 1 of this invention.
[0030] Figure 9 The fluorescence emission spectrum of the yellow-red PS-AIE-SiO2@GOx nanocomposite material prepared in Example 3 of this invention is shown.
[0031] Figure 10 The fluorescence emission spectrum of the blue PS-AIE-SiO2@GOx nanocomposite material prepared in Example 4 of this invention is shown.
[0032] Figure 11 The images show the fluorescence images of the green, blue, and yellow-red PS-AIE-SiO2@GOx nanocomposites prepared in Examples 2-4 of this invention.
[0033] Figure 12 The motion trajectory diagrams of the PS-AIE-SiO2@GOx nanocomposite material prepared in Example 2 of the present invention under different concentrations of glucose are shown.
[0034] Figure 13 The mean square displacement diagrams of the PS-AIE-SiO2@GOx nanocomposite material prepared in Example 2 of this invention under different glucose concentrations are shown.
[0035] Figure 14 This is a schematic diagram of the structure of multiple detection lines and control lines in the multicolor immunochromatographic test strip of the present invention.
[0036] Figure 15 This is a fluorescence imaging image of the multicolor immunochromatographic test strip of the present invention after detecting different target analytes.
[0037] Figure 16This is a standard curve diagram for the quantitative detection of target analytes using the multicolor immunochromatographic test strip of the present invention.
[0038] Figure 17 This is a comparison of the detection signals of the immune probe prepared in Example 1 of the present invention and the immune probe prepared in Comparative Example 1 without glucose oxidase modification.
[0039] Figure 18 shows the specificity detection results of the multicolor immunochromatographic test kit of the present invention; wherein, (a) in Figure 18 is the specificity test diagram when the target analyte is CEA; (b) in Figure 18 is the specificity test diagram when the target analyte is CA15-3; and (c) in Figure 18 is the specificity test diagram when the target analyte is CA125.
[0040] Figure 19 This is a flowchart illustrating the detection process of the multicolor immunochromatographic test kit using real samples according to the present invention.
[0041] Figure 20 shows the regression fitting curves of the multicolor immunochromatographic test kit detection and chemiluminescence detection of the present invention; wherein, Figure 20(a) is the regression fitting curve of the multicolor immunochromatographic test kit detection and chemiluminescence detection when the target analyte is CA125; Figure 20(b) is the regression fitting curve of the multicolor immunochromatographic test kit detection and chemiluminescence detection when the target analyte is CA15-3; Figure 20(c) is the regression fitting curve of the multicolor immunochromatographic test kit detection and chemiluminescence detection when the target analyte is CEA. Detailed Implementation
[0042] The present invention will be further described in detail below with reference to the accompanying drawings and embodiments: The following examples use instruments and equipment conventional in the art. Experimental methods in the following examples, unless otherwise specified, are generally performed under standard conditions or as recommended by the manufacturer. All raw materials used in the following examples are conventional commercially available products with specifications in the art, unless otherwise stated.
[0043] In this invention, PS-AIE represents aggregation-induced emission polystyrene nanospheres; PS-AIE-SiO2 represents PS-AIE-SiO2 asymmetric nanoparticles; PBSG represents PS-AIE-SiO2@GOx nanocomposite material, i.e., aggregation-induced emission asymmetric nanomotor modified with glucose oxidase; and PBSG@mAb represents an immunoprobe reagent obtained by conjugating PS-AIE-SiO2@GOx nanocomposite material with an antibody to be labeled.
[0044] A multicolor immunochromatographic assay kit based on a glucose oxidase-driven aggregation-induced emission nanomotor includes a multicolor immunochromatographic test strip and individually packaged immunoprobe reagents. The multicolor immunochromatographic test strip includes a base plate and a sample pad, filter paper, nitrocellulose membrane, and absorbent paper sequentially overlapped and adhered to the base plate. The immunoprobe reagent is PBSG@mAb buffer. The PBSG@mAb buffer is prepared from PS-AIE-SiO2@GOx nanocomposite material and the antibody to be labeled. The PS-AIE-SiO2@GOx nanocomposite material is asymmetric snowman-shaped nanoparticles (Janus structure), with one end being an aggregation-induced emission polystyrene nanosphere and the other end being a hemispherical SiO2 nanoparticle modified with glucose oxidase.
[0045] Example 1 This embodiment provides a method for preparing PBSG@mAb buffer, as detailed below: 5 mg of PS-AIE-SiO2@GOx nanocomposite material was mixed with 5 μg of the antibody to be labeled and incubated for 60 min. Then, 5% casein was added, and the mixture was incubated for another 60 min at room temperature. The precipitate was collected by centrifugation and reconstituted with 0.01 mol of phosphate-buffered saline (PBS) at pH 7.0 to 1 / 10 of the initial volume of the PS-AIE-SiO2@GOx nanocomposite material, yielding PBSG@mAb buffer, which is the immunoprobe reagent. The blocking agent in this embodiment can be selected from 3%–20% casein; alternatively, 3%–20% bovine serum albumin or skim milk powder can also be used as the blocking agent in this embodiment.
[0046] The antibody to be labeled in this embodiment is an anti-CEA monoclonal antibody; in addition, polyclonal antibodies, nanobodies, and phage expression antibodies are also applicable to this embodiment.
[0047] Example 2 This embodiment provides a method for preparing PS-AIE-SiO2@GOx nanocomposite materials, as detailed below: Step 1: Preparation of aggregation-induced emission polystyrene nanospheres PS-AIE; Step 1.1: Add 3.0 mL of potassium persulfate with a concentration of 6 mM and 3.0 mL of sodium dodecyl sulfate with a concentration of 1 mM to 5.6 mL of ultrapure water, and sonicate (ultrasonic power of 200 W) for 2 min to uniformly disperse potassium persulfate and sodium dodecyl sulfate in ultrapure water to obtain the first dispersion in aqueous phase. Step 1.2: Add 15 mg of green AIE fluorescent molecules to 1 mL of styrene monomer and sonicate (ultrasonic power of 200 W) for 2 min to uniformly disperse the AIE fluorescent molecules BTPEBT in the styrene monomer, thus obtaining a second dispersion in the oil phase. The preparation method of the green AIE fluorescent molecule in step 1.2 is as follows: a) Add 274.8 mg (0.60 mmol) of a boronic acid or boronic ester intermediate containing a triphenylpyridine structure, 70.6 mg (0.24 mmol) of 4,7-dibromo-2,1,3-benzothiadiazole, 27.7 mg (24 μmol) of Pd(PPh3)4, 662.4 mg (4.80 mmol) of K2CO3 and 7.8 mg (24 μmol) of tetrabutylammonium bromide to a Schlenk tube, then add 2.4 mL of deionized water and 20 mL of toluene; b) After degassing the mixture obtained in step a), heat it at 90°C for 48 h under an argon atmosphere; c) After the reaction is complete, add 100 mL of dichloromethane to the reaction system of step b) for dilution, separate the organic phase, and wash with water; after drying the organic phase with anhydrous magnesium sulfate, remove the solvent (water and toluene) under reduced pressure to obtain the crude product; d) The crude product was purified by silica gel column chromatography using a 9:2 (v / v) mixture of n-hexane and dichloromethane as eluent. After separation and purification, the AIE fluorescent molecule BTPEBT was obtained. This AIE fluorescent molecule BTPEBT was a bright green solid with a yield of 71%.
[0048] The green AIE fluorescent molecules (4,7) double [4 (1,2,2 [Triphenylvinyl]phenyl 2,1,3 Benzo[a]oxadiazole (BTPEBT) has an excitation wavelength of 415 nm and an emission wavelength of 545 nm. Its molecular structure is as follows: Step 1.3: Add all of the first dispersion to all of the second dispersion (oil phase) dropwise within 5 min, and sonicate (ultrasonic power of 200 W) for 10 min to make the first dispersion uniformly dispersed in the second dispersion to form a homogeneous emulsion system; place the homogeneous emulsion system under a nitrogen or argon atmosphere and heat and stir at 66℃ and 330 rpm for 20 h to carry out the polymerization reaction to obtain the first mixed reaction solution; Step 1.4: Centrifuge the mixed reaction solution at 3000 rpm for 10 min, discard the supernatant to obtain the precipitate; wash the precipitate three times with ultrapure water and / or ethanol to remove unreacted styrene monomers, free AIE fluorescent molecules, residual sodium dodecyl sulfate and other byproducts; dry the washed precipitate (drying temperature 50℃, drying time 24 h) to obtain bright green aggregation-induced emission polystyrene nanospheres PS-AIE for later use; The method in this embodiment differs from the existing methods that typically use post-loading, swelling adsorption, or physical embedding to prepare aggregation-induced emission polystyrene nanospheres. Instead, it introduces fluorescent functional units (AIE fluorescent molecules BTPEBT) with aggregation-induced emission properties during the polymerization of polystyrene microspheres (styrene monomers). This allows the AIE fluorescent molecules to be in-situ embedded and uniformly dispersed during the formation of the polymer network structure, thereby constructing an integrated fluorescent microsphere structure in which the fluorescent group is highly integrated with the polymer matrix.
[0049] This embodiment utilizes the properties of AIE fluorescent molecules in an aggregated state to suppress intramolecular motion, reduce non-radiative energy loss, and enhance radiative transitions. Through the spatial confinement of fluorescent molecules by the polystyrene polymer network, it effectively avoids the fluorescence quenching phenomenon caused by high-concentration aggregation in traditional organic fluorescent dyes, allowing the resulting polystyrene microspheres to maintain strong fluorescence emission even under high fluorescence loading conditions. Simultaneously, the in-situ polymerization method enhances the binding stability between fluorescent molecules and the polymer matrix, reducing problems such as leakage, migration, and fluorescence attenuation caused by the physical adsorption of fluorescent molecules in traditional swelling methods. This improves the photostability, storage stability, and signal reliability of the fluorescent microspheres during detection.
[0050] The PS-AIE aggregation-induced emission polystyrene nanospheres prepared in Example 2 were observed by transmission electron microscopy, and the results are as follows: Figure 1 As shown; by Figure 1 It can be seen that the synthesized PS-AIE aggregation-induced emission polystyrene nanospheres have a spherical structure, uniform particle size, and a diameter of 210 nm.
[0051] Step 2: Preparation of PS-AIE-SiO2 asymmetric nanoparticles; Step 2.1: Take 1g of the PS-AIE aggregation-induced emission polystyrene nanospheres prepared in Step 1 and disperse them in 20mL of ultrapure water. Add 8.0 μL of concentrated ammonia solution with a mass fraction of 28%, stir at 300rpm for 60min at room temperature, and then heat to 70℃ and stir at 300rpm for 1h to obtain an alkaline dispersion containing PS-AIE nanospheres. Step 2.2: Dissolve 20.0 mg of potassium persulfate in 12 mL of ultrapure water, add 0.02 g of sodium dodecyl sulfate and 1.0 g of 3-methacryloyloxypropyltrimethoxysilane in sequence, and sonicate for 10 min (ultrasonic power of 200 W) to obtain a silicon-containing emulsion. Step 2.3: Under stirring conditions of 70℃ and 300 rpm, the entire emulsion containing the silicon source was added dropwise to the alkaline dispersion containing all PS-AIE nanospheres within 20 min. The polymerization reaction was carried out at 70℃ for 12 h, allowing SiO2 to grow in situ on one side of the PS-AIE nanospheres, forming an asymmetric snowman-like structure (Janus structure), thus obtaining the second mixed reaction solution. After the reaction was completed, the second mixed reaction solution was centrifuged at 8000 rpm for 10 min, and the supernatant was discarded to obtain the precipitate. The precipitate was washed three times with a mixture of ultrapure water and ethanol, and then dispersed in ethanol to obtain PS-AIE-SiO2 asymmetric nanoparticles for later use. This invention utilizes PS-AIE aggregation-induced emission polystyrene nanospheres as an organic polymer substrate to achieve selective growth of silica components on the PS surface via an interface-induced mechanism. Specifically, using MPS, a silicon-based precursor with siloxane groups, as the reactant monomer, the methacrylic acid double bond (C=C) in the MPS molecule undergoes free radical polymerization under the action of an initiator, forming an interfacial bond with the polymer segments on the PS microsphere surface. Simultaneously, the methoxysilane groups (Si–OCH3) in MPS undergo hydrolysis under alkaline conditions and further condense to form a Si-O-Si network structure, thereby generating a silica structure. During this process, due to differences in the interfacial properties, surface energy, and active site distribution on the PS-AIE microsphere surface, MPS preferentially undergoes adsorption, polymerization, and condensation reactions in localized regions of the PS surface, forming initial silica nucleation regions. Subsequently, the formed silica regions serve as active interfaces for further condensation growth, promoting the continued aggregation and growth of subsequent MPS hydrolysis products into these regions, ultimately forming a locally enriched SiO2 asymmetric structure rather than a uniformly coated core-shell structure. Its formation process is essentially an interfacial selective growth process synergistically regulated by free radical polymerization kinetics and silicon-oxygen network condensation kinetics. By adjusting the concentrations of initiator, catalyst, and MPS precursor, the size, coverage, and spatial distribution of the SiO2 structure can be controlled, thereby obtaining PS-AIE-SiO2 asymmetric nanoparticles with a snowman-like (Janus structure) structure. This structure allows the PS-AIE region to retain fluorescence signal output function, while the SiO2 region provides abundant surface hydroxyl groups and functionalization sites, which can be further used for GOx immobilization to realize the construction of glucose-driven nanomotors.
[0052] The PS-AIE-SiO2 nanoparticles prepared in Example 2 were observed by transmission electron microscopy and scanning electron microscopy, respectively. The results are as follows: Figure 2 and Figure 3 As shown. By Figure 2 and Figure 3 It can be seen that the synthesized PS-AIE-SiO2 asymmetric nanoparticles have an asymmetric snowman-like structure (Janus structure), with one end being a PS-AIE aggregation-induced emission polystyrene nanosphere and the other end being a hemispherical SiO2 nanoparticle.
[0053] Step 3: Preparation of PS-AIE-SiO2@GOx nanocomposite material (PBSG); Step 3.1: Disperse 10 mg of the PS-AIE-SiO2 asymmetric nanoparticles prepared in Step 2 in 5 mL of ethanol, then add 50 μL of 97% (w / w) 3-aminopropyltriethoxysilane (APTES) and 100 μL of 28% (w / w) concentrated ammonia. Stir and heat at 60 °C and 300 rpm for 6 h to amination the surface of the PS-AIE-SiO2 asymmetric nanoparticles, obtaining the third mixed reaction solution. After the reaction is complete, centrifuge the third mixed reaction solution at 8000 rpm for 10 m, discard the supernatant to obtain the precipitate. Wash the precipitate three times with a mixture of ultrapure water and ethanol to obtain amination-treated PS-AIE-SiO2 nanoparticles. Step 3.2: Disperse 5 mg of the aminated PS-AIE-SiO2 nanoparticles prepared in Step 3.1 in 5 mL of phosphate (PBS) buffer, add 1 mL of 2.5% glutaraldehyde aqueous solution (i.e., 2.5 g glutaraldehyde per 100 mL of aqueous solution), and vortex at 150 r / min for 2 h at room temperature to activate the amino groups on the surface of the PS-AIE-SiO2 nanoparticles, obtaining the fourth mixed reaction solution; after the reaction is completed, centrifuge the fourth mixed reaction solution at 12000 rpm for 10 h, discard the supernatant to obtain the precipitate; wash the precipitate three times with anhydrous ethanol to remove excess glutaraldehyde, and obtain the activated PS-AIE-SiO2 nanoparticles; Step 3.3: 5 mg of activated PS-AIE-SiO2 nanoparticles were redispersed in 5 mL of PBS buffer, and 5 mg of glucose oxidase GOx was added. The mixture was incubated at room temperature for 12 h to immobilize glucose oxidase GOx on the surface of the hemispherical SiO2 nanoparticles, resulting in the fifth mixed reaction solution. After the incubation reaction was completed, the fifth mixed reaction solution was centrifuged at 8000 rpm for 10 min, and the supernatant was discarded to obtain the precipitate. The precipitate was washed three times with PBS buffer to remove glucose oxidase GOx that was not bound to the SiO2 nanoparticles. The washed precipitate was then redissolved in PBS buffer to obtain the green PS-AIE-SiO2@GOx nanocomposite material, i.e., PBSG.
[0054] In this embodiment, glucose oxidase GOx is immobilized and modified onto the surface of hemispherical SiO2 nanoparticles using an amination modification method. In addition, physical adsorption, covalent coupling, silanization modification, carboxylation modification, glutaraldehyde crosslinking, or EDC / NHS coupling are all applicable to this embodiment.
[0055] This embodiment utilizes the abundant silanol (Si–OH) active sites in the hemispherical SiO2 region on the surface of PS-AIE-SiO2 asymmetric nanoparticles to achieve stable immobilization of glucose oxidase (GOx) through an amination modification method. First, the silanol groups on the SiO2 surface undergo a silanization reaction with an aminosilane coupling agent, introducing amino functional groups into the SiO2 region and forming a reactive amino (–NH2) modified layer on the particle surface. Subsequently, utilizing the coupling effect between the amino groups and the carboxyl groups on the GOx molecule surface, the carboxyl groups are activated by a carbodiimide condensing agent (such as EDC / NHS), promoting amide bond formation and achieving covalent immobilization of GOx molecules in the hemispherical SiO2 region, ultimately obtaining the PS-AIE-SiO2@GOx nanocomposite material.
[0056] The PS-AIE-SiO2@GOx nanocomposite material synthesized in Example 2 was observed by scanning electron microscopy, and the results are as follows: Figure 4 As shown; by Figure 4 It can be seen that the coupling of glucose oxidase (GOx) does not affect the asymmetry of PS-AIE-SiO2 asymmetric nanoparticles.
[0057] The particle sizes of the PS-AIE aggregation-induced emission polystyrene nanospheres, PS-AIE-SiO2 asymmetric nanoparticles, and PS-AIE-SiO2@GOx nanocomposites from the examples were compared, and the results are as follows: Figure 5 As shown; by Figure 5It can be seen that the particle size of PS-AIE aggregation-induced emission polystyrene nanospheres is 315 nm, the particle size of PS-AIE-SiO2 asymmetric nanoparticles is 671 nm, and the particle size of PS-AIE-SiO2@GOx nanocomposite is 734 nm, indicating that PS-AIE-SiO2@GOx nanocomposite was successfully synthesized by the above method.
[0058] Elemental distribution analysis was performed on the PS-AIE-SiO2@GOx nanocomposite material, and the results are as follows: Figure 6 As shown. By Figure 6 It is known that the enzyme contains Si, N, and O elements, thus proving that glucose oxidase GOx was successfully modified on the surface of PS-AIE-SiO2 asymmetric nanoparticles.
[0059] Example 3 This embodiment provides a method for preparing PS-AIE-SiO2@GOx nanocomposite materials, as detailed below: The difference from Example 2 is that in step 1.2 of this example, 15 mg of green AIE fluorescent molecules are replaced with 15 mg of red AIE fluorescent molecules, and finally yellow-red PS-AIE-SiO2@GOx nanocomposite material is obtained.
[0060] The preparation method of the red AIE fluorescent molecule is as follows: i 200 mg (0.59 mmol) of (4-(naphth-1-yl(phenyl)amino)phenyl)boronic acid, 63 mg (0.21 mmol) of 4,7-dibromobenzo[c][1,2,5]thiadiazole, 22 mg (0.02 mmol) of tetra(triphenylphosphine)palladium[Pd(PPh3)4] and 79 mg (0.57 mmol) of potassium carbonate (K2CO3) were added to a 50 mL three-necked flask. Under nitrogen protection, 20 mL of a 2:1 mixture of tetrahydrofuran and water was added to the three-necked flask. ii ) steps i The resulting mixture was heated to 85°C and stirred continuously at 330 rpm for 48 h to allow the raw materials in the mixture to undergo a full coupling reaction. iii After the coupling reaction is complete, proceed with step... ii The resulting reaction system was cooled to 25°C, and the solvent in the reaction system was removed by vacuum evaporation to obtain the crude reaction product. ivThe crude reaction product was extracted by adding a mixture of water and dichloromethane in a volume ratio of 3:1. The extraction was repeated 3 times, and the resulting organic phases were combined. The combined organic phases were dried with anhydrous sodium sulfate, and the desiccant (anhydrous sodium sulfate) was removed by filtration. The organic solvent (dichloromethane) was removed under reduced pressure to obtain the crude DPNA-BT product. v The crude DPNA-BT product was purified by silica gel column chromatography using a petroleum ether-dichloromethane mixed solvent with a volume ratio of 15:1 as the eluent. After separation and purification, an orange solid, i.e., a red AIE fluorescent molecule, was obtained.
[0061] The red AIE fluorescent molecule (N,N′) (benzo[c][1,2,5]thiadiazole) 4,7 Dibasic bi(4,1) Phenylidene bis(N) Phenyl 1 Naphthylamine (DPNA-BT) has an excitation wavelength of 470 nm and an emission wavelength of 615 nm. Its molecular structure is as follows: Example 4 This embodiment provides a method for preparing PS-AIE-SiO2@GOx nanocomposite materials, as detailed below: The difference from Example 2 is that in step 1.2 of this example, 15 mg of green AIE fluorescent molecules were replaced with 15 mg of blue AIE fluorescent molecules, ultimately yielding a blue PS-AIE-SiO2@GOx nanocomposite material. The blue AIE fluorescent molecule (tetraphenylethylene, TPE) was purchased from Aladdin Reagents Co., Ltd. The blue AIE fluorescent molecule has an excitation wavelength of 365 nm and an emission wavelength of 475 nm. Its molecular structure is as follows: Comparative Example 1 PS-AIE-SiO2 asymmetric nanoparticles were prepared according to steps 1 and 2 in Example 2, without glucose oxidase GOx modification in step 3, to obtain unmodified PS-AIE-SiO2 asymmetric nanoparticles.
[0062] Fluorescence emission spectroscopy was performed on the unmodified PS-AIE-SiO2 asymmetric nanoparticles in Comparative Example 1, and the results are as follows: Figure 7 As shown; by Figure 7 It can be seen that the emission wavelength of the unmodified green PS-AIE-SiO2 asymmetric nanoparticles is 531 nm.
[0063] Unmodified PS-AIE-SiO2 asymmetric nanoparticles were observed using laser confocal microscopy, and the results are as follows: Figure 8 As shown. By Figure 8 It can be seen that the fluorescence distribution of unmodified PS-AIE-SiO2 asymmetric nanoparticles is uniform, and the fluorescence is emitted only on one side of the PS microspheres; The green, yellow-red, and blue PS-AIE-SiO2@GOx nanocomposites prepared in Examples 2-4 were used to prepare the PBSG@mAb buffer in Example 1, respectively, to obtain green, yellow-red, and blue PBSG@mAb buffers. By adding the different colored PBSG@mAb buffers to the conjugate pad, different colored PBSG@mAb immunoprobes were formed. These different colored PBSG@mAb immunoprobes correspond to different detection lines on the nitrocellulose membrane, thereby achieving multi-target, multi-color immunochromatographic detection.
[0064] from Figure 9 It can be seen that the emission wavelength of the yellow-red PS-AIE-SiO2@GOx nanocomposite material prepared in Example 3 is 610 nm; from Figure 10 It can be seen that the blue PS-AIE-SiO2@GOx nanocomposite material prepared in Example 4 has an emission wavelength of 475 nm; the green PS-AIE-SiO2@GOx nanocomposite material in Example 2 has an emission wavelength of 531 nm (same as above). Figure 7 The emission wavelengths of unmodified green PS-AIE-SiO2 asymmetric nanoparticles were measured, demonstrating that the emission wavelengths of the three colors of PS-AIE-SiO2@GOx nanocomposites do not interfere with each other, making them suitable for constructing multi-color PBSG@mAb immune probes.
[0065] Figure 11 Fluorescence images of PS-AIE-SiO2@GOx nanocomposites in different colors. The emission color of PS-AIE-SiO2@GOx nanocomposites (PBSG nanomotors) can be modulated by changing AIE fluorescent molecules of different colors.
[0066] The PS-AIE-SiO2@GOx nanocomposite material prepared in Example 2 was dispersed in PBS buffer containing different concentrations of glucose. The motion trajectory of the PBSG nanomotor was recorded using a microscopic imaging system, and its mean square displacement was analyzed.
[0067] Specifically, glucose solutions of different concentrations were prepared: 0 mmol / L, 5 mmol / L, 10 mmol / L, 20 mmol / L, and 50 mmol / L. PBSG nanocomposite materials were added to these glucose solutions, mixed thoroughly, and then dropped onto glass slides. The motion of the nanoparticles was recorded under a microscope over a certain period. The trajectory of individual PBSG nanoparticles was tracked using image analysis software, and their mean square displacement was calculated.
[0068] See Figure 12 Under different glucose concentrations, the PBSG nanocomposite material prepared in Example 1 exhibited different motion trajectories. With increasing glucose concentration, the range of motion of PBSG gradually increased, and the motion trajectory significantly lengthened. (See also...) Figure 13 The mean square displacement (MSD) results of PBSG at different glucose concentrations showed that the MSD of PBSG increased significantly with increasing glucose concentration. This result indicates that the glucose oxidase modified on the PBSG surface can catalyze the glucose reaction, generating local chemical driving forces, thereby endowing the PBSG nanocomposite with active motion capabilities. Compared with ordinary fluorescent probes that rely solely on capillary flow and Brownian motion, the PBSG nanomotors exhibit stronger motion capabilities in the presence of glucose, which is beneficial for improving their migration, collision, and enrichment efficiency in immunochromatographic systems.
[0069] Multiple detection lines and one control line are sequentially arranged on the nitrocellulose membrane along the chromatography direction. The multiple detection lines are formed by spraying various capture antibodies, adjusted in concentration and targeting different analytes, onto the surface of the nitrocellulose membrane. The control line is formed by spraying anti-mouse antibodies or anti-rabbit antibodies, adjusted in concentration and used to recognize PBSG@mAb, onto the surface of the nitrocellulose membrane. In this embodiment, three different fluorescent PBSG@mAb immunoprobe reagents were prepared. Specifically, a green PS-AIE-SiO2@GOx nanocomposite material was conjugated with an anti-CA-125 monoclonal antibody to obtain a green PBSG@anti-CA-125 mAb immunoprobe; a yellow-red PS-AIE-SiO2@GOx nanocomposite material was conjugated with an anti-CA-153 monoclonal antibody to obtain a yellow-red PBSG@anti-CA-153 mAb immunoprobe; and a blue PS-AIE-SiO2@GOx nanocomposite material was conjugated with an anti-CEA monoclonal antibody to obtain a blue PBSG@anti-CEA mAb immunoprobe.
[0070] Accordingly, three detection lines, T1, T2, and T3, are sequentially set on the nitrocellulose membrane. The T1 detection line is coated with a capture antibody corresponding to CA-125 to capture the immune complex formed by the green PBSG@anti-CA-125 mAb immunoprobe; the T2 detection line is coated with a capture antibody corresponding to CA-153 to capture the immune complex formed by the yellow PBSG@anti-CA-153 mAb immunoprobe; and the T3 detection line is coated with a capture antibody corresponding to CEA to capture the immune complex formed by the blue PBSG@anti-CEA mAb immunoprobe. Line C serves as a control line to capture any PBSG@mAb immunoprobes that do not bind to the detection lines, thus determining whether the chromatographic process and immunoprobe release are normal.
[0071] See Figure 14 Specifically, the first target detection antibody (tumor marker carbohydrate antigen CA-125) with adjusted concentration was sprayed onto the surface of a nitrocellulose membrane as the first detection line T1; the second target detection antibody (tumor marker carbohydrate antigen CA-153) with adjusted concentration was sprayed onto the surface of the nitrocellulose membrane as the second detection line T2; the third target detection antibody (carcinoembryonic antigen CEA) with adjusted concentration was sprayed onto the surface of the nitrocellulose membrane as the third detection line T3; and the anti-mouse antibody with adjusted concentration was sprayed onto the surface of the nitrocellulose membrane as the control line C. The three detection lines (T1, T2, and T3) and the control line (C line) were spaced apart from each other, and the spraying amount of the three target detection antibodies and the anti-mouse antibody was 0.5~1.0 μL / cm. The nitrocellulose membranes sprayed with the three target detection antibodies and the anti-mouse antibody were dried at 37 ℃ for 12 h and then stored in a dry environment at room temperature for later use.
[0072] In this embodiment, the reagent used to adjust the concentration of the target analyte capture antibody is a 0.01 M PBS buffer with a pH of 7.5, which can dilute the target analyte capture antibody to 0.5~2.0 mg / mL; the reagent used to adjust the concentration of the anti-mouse antibody is a 0.01 M PBS buffer with a pH of 7.5, which can dilute the anti-mouse antibody to 0.5~1.5 mg / mL; the spray volume of the above reagents is 0.75~0.84 μL / cm; the three detection lines (T1, T2 and T3) are spaced 3~8 mm apart from each other, as are the detection lines (T1, T2 and T3) and the control line (C).
[0073] The multicolor immunochromatographic test strip prepared in this invention has three detection lines and one control line. The three detection lines distributed on the nitrocellulose membrane can correspond to different target analytes, and the PBSG@mAb immunoprobes of different colors (green, yellow-red, and blue) distributed on the conjugate pad correspond to different fluorescence channels, thereby realizing multicolor and multi-target detection. The control line distributed on the nitrocellulose membrane is used to identify the PBSG@mAb immunoprobes and determine whether the test strip detection results are valid.
[0074] Assembly process of a multicolor immunochromatographic assay kit based on glucose oxidase-driven aggregation-induced luminescent nanomotors: Preparation of multicolor immunochromatographic test strips: The sample pad, filter paper, nitrocellulose membrane with three detection lines and one control line, and absorbent paper are sequentially overlapped and glued onto a PVC base plate. After assembly, the strips are cut into multicolor immunochromatographic test strips. The cut multicolor immunochromatographic test strips are then placed into plastic housings (the sample application holes of the housings correspond to the positions of the sample pads, and the observation windows of the housings correspond to the positions of the nitrocellulose membranes), pressed tightly, placed in aluminum foil bags, desiccant is added, and the bags are sealed for storage. The sample pad dimensions are 1×30 cm, the filter paper dimensions are 0.8×30 cm, the nitrocellulose membrane dimensions are 2.5×30 cm, the absorbent paper dimensions are 1.5×30 cm, the PVC base plate dimensions are 5.5×30 cm, and the cut multicolor immunochromatographic test strip dimensions are 4×55 mm. Prepare various colored immunoprobe reagents (PBSG@mAb buffer), and quantitatively dispense the immunoprobe reagents into reagent tubes in the form of independent liquid preparations, and seal the tubes.
[0075] In addition, the multicolor immunochromatographic test kit is equipped with an enzyme-labeled well reactor, which is used to mix the immunoprobe reagent, the sample to be tested and the glucose substrate, and then add them to the sample pad for immunochromatographic reaction to detect the sample.
[0076] A detection method based on a multicolor immunochromatographic assay kit using glucose oxidase-driven aggregation-induced luminescent nanomotors: Add 30-40 μL of three different colored PBSG@mAb buffers (specifically, a complex of green PBSG@anti-CA-125 mAb immunoprobe, yellow PBSG@anti-CA-153 mAb immunoprobe, and blue PBSG@anti-CEA mAb immunoprobe) and 30-50 μL of serum test sample to the ELISA well reactor. Using the ELISA well reactor, add the mixture of the three different colored PBSG@mAb buffers and serum test sample to the sample wells of the multicolor immunochromatographic test strip, thus adding it to the sample pad of the multicolor immunochromatographic test strip. Under capillary action, the sample migrates towards the conjugate pad and the nitrocellulose membrane, releasing the green PBSG@anti-CA-125 mAb immunoprobe, yellow PBSG@anti-CA-153 mAb immunoprobe, and blue PBSG@anti-CEA mAb immunoprobe from the conjugate pad. During chromatography, glucose oxidase (GOx) immobilized on the surface of PBSG nanomotors catalyzes the glucose reaction. The asymmetric structure of the nanoparticles creates a local chemical concentration gradient, causing the immunoprobes to move actively. This increases the probability of collision and binding between the immunoprobes and the target antigen, promoting the immune response. If the serum sample contains CA-125, CA-153, or CEA, the corresponding colored PBSG immunoprobes first specifically bind to the target and migrate with the liquid flow to the corresponding test line. Specifically, line T1 is coated with CA-125 capture antibody, capturing the immune complex formed by the green PBSG@anti-CA-125 mAb immunoprobe; line T2 is coated with CA-153 capture antibody, capturing the immune complex formed by the yellow PBSG@anti-CA-153 mAb immunoprobe; and line T3 is coated with CEA capture antibody, capturing the immune complex formed by the blue PBSG@anti-CA-153 mAb immunoprobe, generating corresponding fluorescent signals. Immunoplasm not captured by the test lines continues to migrate to the control line C and is captured, used to determine whether the test strip detection process is normal. After the chromatography reaction was completed, fluorescence signals from the T1, T2, and T3 detection lines were collected using a fluorescence detection device. Based on the fluorescence intensity of the corresponding detection lines and the built-in standard curve (y = 2359log(x) + 1592, R...), the fluorescence signals were analyzed. 2 = 0.99), which can calculate the concentration of the target analyte in the serum test sample to achieve quantitative detection, and then observe the test line and control line through the observation window to achieve qualitative judgment.
[0077] This invention combines multicolor AIE fluorescence encoding, glucose oxidase-driven active motion, and immunochromatographic specific recognition to achieve simultaneous detection of multiple targets while improving the migration and binding efficiency of immune probes, thereby enhancing the sensitivity and detection efficiency of immunochromatographic detection.
[0078] See Figure 15 The multicolor immunochromatographic test strip of the present invention generates different colored fluorescent signals on the corresponding detection lines after detecting CEA, CA15-3, and CA125 target analytes, indicating that the multicolor immunochromatographic test strip of the present invention can achieve multicolor, multi-target immunochromatographic detection.
[0079] Different concentrations of CEA, CA15-3, and CA125 target analyte standards were added to the negative matrix to prepare a series of standard samples. The standard samples were then tested according to the above detection method. After the reaction, the fluorescence intensity at each detection line was recorded using a fluorescence reading device. A standard curve was established with the target analyte concentration on the x-axis and the fluorescence intensity at the detection line on the y-axis, as shown below. Figure 16 The standard curve for the quantitative detection of target analytes using multicolor immunochromatographic test strips is shown; from Figure 16 It can be concluded that, within a certain concentration range, there is a good linear correlation between the concentration of the target analyte and the intensity of the fluorescence signal, indicating that the test strip of the present invention can be used for the quantitative detection of the target analyte.
[0080] Performance verification Signal strength and detection sensitivity verification To verify the enhancement effect of glucose oxidase-driven action on immunochromatographic detection signal, the unmodified glucose oxidase PS-AIE-SiO2 asymmetric nanoparticles prepared in Comparative Example 1 were used as immunoprobes and set as the control group. The PS-AIE-SiO2@GOx nanocomposite material prepared in Example 1 was used as immunoprobes and set as the experimental group. Immunochromatographic detection was performed according to the detection method of the multicolor immunochromatographic test strip described above.
[0081] See Figure 17 The test strip using the PBSG@mA immunoprobe produced a stronger fluorescence signal at the detection line. This result indicates that the driving force of GOx-catalyzed glucose production can promote the migration and enrichment of the immunoprobe in the chromatographic system, thereby enhancing the detection signal and improving detection sensitivity.
[0082] Verification of the specific recognition capability of multicolor immunochromatographic test kit To evaluate the specificity of the multicolor immunochromatographic test kit of this invention, target analytes (CEA, CA125, and CA15-3) and several non-target interfering substances (HCG, VEGF, PCT, and PSA) were selected and detected using the multicolor immunochromatographic test kit of this invention. Specifically, the target analytes and non-target interfering substances were added to the negative matrix respectively, and the detection was performed according to the detection method of the multicolor immunochromatographic test kit. After the reaction was completed, the fluorescence signal at each detection line was read, and the signal differences between different samples were compared.
[0083] Referring to (ac) in Figure 18, the specific detection results of the multicolor immunochromatographic test strip of the present invention show that the detection line corresponding to the target analyte produces a significant fluorescence signal, while the fluorescence signal caused by non-target interfering substances is low, indicating that the test strip of the present invention has good specific recognition ability.
[0084] Verification of the accuracy of multicolor immunochromatographic test kit See Figure 19 To evaluate the accuracy of the multicolor immunochromatographic test strip of this invention in actual sample testing, serum from several breast cancer patients was selected and tested using both the multicolor immunochromatographic test strip prepared in this invention and the clinically commonly used chemiluminescence method. Specifically, after preprocessing the real samples according to the requirements of immunochromatographic detection, the detection method of the aforementioned multicolor immunochromatographic test strip was used for testing; simultaneously, the content of the target analyte in the same sample was detected using chemiluminescence. Regression analysis was performed on the detection results obtained by the two methods to evaluate the correlation between them.
[0085] Referring to (ac) in Figure 20, the regression curves of the multicolor immunochromatographic test strip of the present invention and the chemiluminescence method show that the detection results of the two methods have a good correlation, indicating that the test strip of the present invention can be used to detect the target analyte (serum of breast cancer patients) in real samples and has good potential for practical application.
[0086] The above description is merely a specific embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any modifications, equivalent substitutions or improvements made by those skilled in the art within the spirit and principles of the present invention should be covered within the scope of protection of the present invention.
Claims
1. A multicolor immunochromatographic assay kit based on glucose oxidase-driven aggregation-induced luminescence nanomotors, comprising multicolor immunochromatographic test strips and individually packaged immunoprobe reagents, wherein the multicolor immunochromatographic test strips comprise a base plate and a sample pad, filter paper, nitrocellulose membrane, and absorbent paper sequentially overlapped and adhered to the base plate, characterized in that, The immunoprobe reagent is PBSG@mAb buffer; the PBSG@mAb buffer is prepared from PS-AIE-SiO2@GOx nanocomposite material and antibody to be labeled; the PS-AIE-SiO2@GOx nanocomposite material is asymmetric snowman-shaped nanoparticles, one end of which is aggregation-induced emission polystyrene nanosphere PS-AIE, and the other end is hemispherical SiO2 nanoparticles modified with glucose oxidase GOx.
2. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescence nanomotors according to claim 1, characterized in that, The aggregation-induced emission polystyrene nanospheres PS-AIE are prepared by encapsulating AIE fluorescent molecules in polystyrene nanospheres PS, and the diameter of the aggregation-induced emission polystyrene nanospheres PS-AIE is 150 nm to 250 nm.
3. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescent nanomotors according to claim 2, characterized in that, The AIE fluorescent molecule is selected from one of the following: green AIE fluorescent molecule BTPEBT, red AIE fluorescent molecule DPNA-BT, and blue AIE fluorescent molecule TPE.
4. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescent nanomotors according to claim 1, characterized in that, The glucose oxidase GOx is modified on the surface of hemispherical SiO2 nanoparticles by any one of the following methods: physical adsorption, covalent coupling, silanization modification, amylation modification, carboxylation modification, glutaraldehyde crosslinking, or EDC / NHS coupling.
5. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescence nanomotors according to claim 1, characterized in that, The PBSG@mAb buffer is prepared by mixing 1-20 mg of PS-AIE-SiO2@GOx nanocomposite material with 5 μg of antibody to be labeled, incubating for 30-150 min, adding blocking agent, continuing incubation at room temperature for 20-120 min, centrifuging to collect the precipitate, and reconstituted.
6. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescent nanomotor according to claim 5, characterized in that, The antibody to be labeled is selected from one of the following: monoclonal antibody, polyclonal antibody, nanobody, or phage expression antibody.
7. The multicolor immunochromatographic detection kit based on glucose oxidase-driven aggregation-induced luminescent nanomotors according to claim 1, characterized in that, The preparation method of the PS-AIE-SiO2@GOx nanocomposite material is as follows: 1) Preparation of aggregation-induced emission polystyrene nanospheres PS-AIE; 3.0 mL of 6 mM potassium persulfate and 3.0 mL of 1 mM sodium dodecyl sulfate were added to 5.6 mL of ultrapure water and sonicated to obtain a first dispersion. 15 mg of AIE fluorescent molecules were added to 1 mL of styrene monomer and sonicated to obtain a second dispersion. All of the first dispersion was added dropwise to all of the second dispersion, and after sonication, polymerization was carried out under an inert gas atmosphere at 60–80 °C and 100–600 rpm for 10–30 h to obtain a first mixed reaction solution. The first mixed reaction solution was centrifuged, washed, and dried sequentially to obtain PS-AIE aggregation-induced emission polystyrene nanospheres (PS-AIE). 2) Preparation of PS-AIE-SiO2 asymmetric nanoparticles; 1 g of the aggregation-induced emission polystyrene nanospheres PS-AIE prepared in step 1) was dispersed in 20 mL of ultrapure water. 8.0 μL of ammonia solution with a mass fraction of 28% was added. The mixture was stirred at room temperature and then heated to 70-75 °C with further stirring to obtain an alkaline dispersion containing PS-AIE nanospheres. 20.0 mg of potassium persulfate was dissolved in 12 mL of ultrapure water. 0.02 g of sodium dodecyl sulfate and 1.0 g of 3-methacryloyloxypropyltrimethoxysilane were added sequentially. After ultrasonic treatment, a silicon-containing emulsion was obtained. Under stirring conditions of 70-75 °C and 300-500 rpm, the entire silicon-containing emulsion was added dropwise to the entire alkaline dispersion containing PS-AIE nanospheres within 20 min. The polymerization reaction was carried out at 70-75 °C for 10-14 h to obtain a second mixed reaction solution. The second mixed reaction solution was centrifuged, and the precipitate was collected. After washing, the precipitate was dispersed in ethanol to obtain PS-AIE-SiO2 asymmetric nanoparticles. 3) Preparation of PS-AIE-SiO2@GOx nanocomposite materials; Take 10 mg of the PS-AIE-SiO2 asymmetric nanoparticles prepared in step 2) and disperse them in 5 mL of ethanol. Then add 50 μL of 97% 3-aminopropyltriethoxysilane and 100 μL of 28% concentrated ammonia. Stir and heat at 60-70℃ and 300-400 rpm for 5-8 h to obtain the third mixed reaction solution. Centrifuge and wash the third mixed reaction solution to obtain aminated PS-AIE-SiO2 nanoparticles. Disperse 5-10 mg of aminated PS-AIE-SiO2 nanoparticles in 5 mL of phosphate buffer and add 1 mL of 2.5% glutaraldehyde aqueous solution. Shake and react at room temperature for 2-4 h to obtain the fourth mixed reaction solution. Centrifuge and wash the fourth mixed reaction solution to obtain activated PS-AIE-SiO2 nanoparticles. Redisperse 5-10 mg of activated PS-AIE-SiO2 nanoparticles in 5 mL of phosphate buffer and add 1-10 mg of glutaraldehyde aqueous solution. mg of glucose oxidase GOx was incubated at room temperature for 4-12 h to obtain the fifth mixed reaction solution. After centrifugation of the fifth mixed reaction solution, the precipitate was collected, washed, and redissolved in PBS buffer to obtain the PS-AIE-SiO2@GOx nanocomposite material.
8. The multicolor immunochromatographic assay kit based on glucose oxidase-driven aggregation-induced luminescence nanomotor according to claim 1, characterized in that, Multiple detection lines and one control line are sequentially arranged on the nitrocellulose membrane along the chromatography direction. The multiple detection lines are formed by spraying capture antibodies of various different target analytes onto the surface of the nitrocellulose membrane, and the control line is formed by spraying a binding protein for recognizing PBSG@mAb onto the surface of the nitrocellulose membrane. The binding protein for recognizing PBSG@mAb is selected from one of anti-mouse antibodies, anti-rabbit antibodies, and streptavidin.
9. A multicolor immunochromatographic assay kit based on a glucose oxidase-driven aggregation-induced luminescent nanomotor according to claim 1, characterized in that, It also includes a housing for holding multicolor immunochromatographic test strips, the housing having a sample application well and an observation window; the sample application well corresponds to the position of the sample pad, and the observation window corresponds to the position of the nitrocellulose membrane.
10. A detection method for a multicolor immunochromatographic assay kit based on glucose oxidase-driven aggregation-induced luminescent nanomotors, comprising detecting the sample using the multicolor immunochromatographic assay kit as described in any one of claims 1-9, specifically as follows: PBSG@mAb buffer and the test sample are added to the enzyme-labeled well reactor, respectively. The mixture of PBSG@mAb buffer and the test sample is then added dropwise to the sample wells of the multicolor immunochromatographic assay kit, allowing the mixture to enter the multicolor immunochromatographic strip for immunochromatographic reaction. After 15 minutes of reaction, the signal data of the test line and control line on the multicolor immunochromatographic assay strip are read. The concentration of the test sample is calculated using the built-in standard curve to achieve quantitative detection. Qualitative judgment is achieved by observing the presence or absence of brown-red on the test line and control line through the observation window of the multicolor immunochromatographic assay kit. The sample volume of the PBSG@mAb buffer and test sample mixture is 50-150 μL / strip. The multicolor immunochromatographic assay strip needs to be irradiated with near-infrared light for 1-10 minutes during the immunochromatographic reaction.
